IP Library Patent Application 14302830
Patent Application
App. No. 14/302,830

DRUG DELIVERY VEHICLES COMPRISING CELLULOSE DERIVATIVES, STARCH DERIVATIVES, AND COMBINATIONS THEREOF

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/302,830
Abstract

A drug delivery vehicle (e.g., a patch, a pill, an intravaginal ring, and an implant) may include a polymer matrix comprising a plasticizer and at least one selected from the group consisting of: a cellulose ester, a cellulose ether, a starch ester, a starch ether, and a combination thereof. A drug may be dispersed in the polymer matrix, in another portion of the drug delivery vehicle, or both.

Claims (23)

1 . A drug delivery vehicle comprising:

an intermediate layer comprising a drug disposed between an adhesive and a backing, wherein one of the intermediate layer and the adhesive are formed by a polymeric matrix that comprises a plasticizer and at least one selected from the group consisting of: a cellulose ester, a cellulose ether, a starch ester, a starch ether, and a combination thereof.

2 . The drug delivery vehicle of claim 1 , wherein the adhesive comprises the polymeric matrix and the plasticizer is in the polymeric matrix at about 15% or greater by weight of the polymeric matrix.

3 . The drug delivery vehicle of claim 1 , wherein the intermediate layer comprises the polymeric matrix and the polymeric matrix consists essentially of the plasticizer, the drug, and the at least one selected from the group consisting of: a cellulose ester, a cellulose ether, a starch ester, a starch ether, and a combination thereof.

4 . The drug delivery vehicle of claim 1 , wherein the polymeric matrix comprises the at least one selected from the group consisting of: the cellulose ester, the cellulose ether, the starch ester, the starch ether, and the combination thereof at about 10% to about 80% by weight of the polymeric matrix.

5 . The drug delivery vehicle of claim 1 , wherein the polymeric matrix further comprises at least one selected from the group consisting of: a polyolefin, an ethylene copolymer, a thermoplastic polyurethane, an acrylic acid polymer, polytetrafluoroethylene, an ethylene vinyl acetate copolymer derivative, a polyester, a polysiloxane, polybutadiene, polyisoprene, poly(methacrylate), poly(methyl methacrylate), a styrene-butadiene-styrene block copolymer, poly(hydroxyethylmethacrylate), poly(vinyl chloride), poly(vinyl acetate), a polyether, a polyacrylonitrile, a polyethylene glycol, polymethylpentene, polybutadiene, polyhydroxy alkanoates, poly(lactic acid), poly(glycolic acid), acrylic acid-based polymers, a methacrylic acid based polymer, a polyanhydride, a polyorthoester, cross-linked poly(vinyl alcohol), neoprene rubber, butyl rubber, polyvinyl acetate phthalate, polyvinyl acetate, shellac, zein, polyethylene oxide, ethylene oxide-propylene oxide copolymers, polyethylene-polypropylene glycol, carbomer, polycarbophil, chitosan, polyvinyl pyrrolidone, poly(vinyl alcohol), a polyethyleneimine, a polyacrylate, a polyacrylamide, a polymethacrylamide, a polyphosphazine, a polyoxazolidine, a polyhydroxyalkylcarboxylic acid, an alginic acid, natural gums, povidone, gelatin, and the like, any derivative thereof, any copolymer thereof, any blend polymer thereof, and combinations thereof.

6 . The drug delivery vehicle of claim 1 , wherein the polymeric matrix further comprises ethylene vinyl acetate copolymer.

7 . The drug delivery vehicle of claim 1 , wherein the polymeric matrix consists essentially of the plasticizer and the at least one selected from the group consisting of: the cellulose ester, the cellulose ether, the starch ester, the starch ether, and the combination thereof.

8 . A drug delivery vehicle comprising:

a core polymer matrix comprising a drug and encompassed by a skin polymer matrix, wherein the core polymer matrix or the skin polymer matrix comprises a plasticizer and at least one selected from the group consisting of: a cellulose ester, a cellulose ether, a starch ester, a starch ether, and a combination thereof.

9 . The drug delivery vehicle of claim 8 , wherein the core polymer matrix consists essentially of the plasticizer, the drug, and the at least one selected from the group consisting of: a cellulose ester, a cellulose ether, a starch ester, a starch ether, and a combination thereof.

10 . The drug delivery vehicle of claim 8 , wherein the polymeric matrix comprises the at least one selected from the group consisting of: the cellulose ester, the cellulose ether, the starch ester, the starch ether, and the combination thereof at about 10% to about 80% by weight of the polymeric matrix.

11 . The drug delivery vehicle of claim 8 , wherein the polymeric matrix further comprises ethylene vinyl acetate copolymer.

12 . The drug delivery vehicle of claim 8 , wherein the polymeric matrix consists essentially of the plasticizer and the at least one selected from the group consisting of: the cellulose ester, the cellulose ether, the starch ester, the starch ether, and the combination thereof.

13 . The drug delivery vehicle of claim 8 dimensioned for use as an intravaginal ring.

14 . The drug delivery vehicle of claim 8 dimensioned for use as a rod-shaped implant.

15 . A drug delivery vehicle comprising:

a bandage with a polymer matrix disposed thereon, wherein the polymer matrix comprises a drug, a plasticizer, and at least one selected from the group consisting of: a cellulose ester, a cellulose ether, a starch ester, a starch ether, and a combination thereof.

16 . The drug delivery vehicle of claim 15 , wherein the polymer matrix is tacky at room temperature.

17 . The drug delivery vehicle of claim 15 , wherein the plasticizer is in the polymeric matrix at about 15% or greater by weight of the polymeric matrix.

18 . The drug delivery vehicle of claim 15 , wherein the at least one selected from the group consisting of: the cellulose ester, the cellulose ether, the starch ester, the starch ether, and the combination thereof is at about 10% to about 80% by weight of the polymeric matrix.

19 . The drug delivery vehicle of claim 15 , wherein the polymeric matrix further comprises ethylene vinyl acetate copolymer.

20 . The drug delivery vehicle of claim 15 , wherein the polymeric matrix consists essentially of the drug, the plasticizer, and the at least one selected from the group consisting of: the cellulose ester, the cellulose ether, the starch ester, the starch ether, and the combination thereof.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 14, 2017
From: CELANESE ACETATE LLC
To: ACETATE INTERNATIONAL LLC
Reel/Frame 044869/0827 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 12, 2014
From: COMBS, MICHAEL; BISSET, WENDY; MILWARD, LIZBETH; LARKIN, ADAM; BUDHAVARAM, NARESH
To: CELANESE ACETATE LLC
Reel/Frame 033089/0762 →